Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 423

2.

Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.

DiGiovanna MP, Stern DF, Edgerton SM, Whalen SG, Moore D 2nd, Thor AD.

J Clin Oncol. 2005 Feb 20;23(6):1152-60.

PMID:
15718311
4.

Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.

Buchholz TA, Tu X, Ang KK, Esteva FJ, Kuerer HM, Pusztai L, Cristofanilli M, Singletary SE, Hortobagyi GN, Sahin AA.

Cancer. 2005 Aug 15;104(4):676-81.

5.

Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.

Hama T, Yuza Y, Saito Y, O-uchi J, Kondo S, Okabe M, Yamada H, Kato T, Moriyama H, Kurihara S, Urashima M.

Oncologist. 2009 Sep;14(9):900-8. doi: 10.1634/theoncologist.2009-0058. Epub 2009 Sep 2. Erratum in: Oncologist. 2009 Oct;14(10):1050.

6.

Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer.

Tsutsui S, Kataoka A, Ohno S, Murakami S, Kinoshita J, Hachitanda Y.

Clin Cancer Res. 2002 Nov;8(11):3454-60.

7.

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, Oka K, Ishimaru Y, Ushio Y.

Cancer Res. 2003 Oct 15;63(20):6962-70.

8.

Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer.

Cunningham MP, Essapen S, Thomas H, Green M, Lovell DP, Topham C, Marks C, Modjtahedi H.

Int J Oncol. 2005 Aug;27(2):317-25.

PMID:
16010411
9.
10.

Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.

Arnes JB, Bégin LR, Stefansson I, Brunet JS, Nielsen TO, Foulkes WD, Akslen LA.

J Clin Pathol. 2009 Feb;62(2):139-46. doi: 10.1136/jcp.2008.056291. Epub 2008 Aug 4.

PMID:
18682421
11.

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

Heimberger AB, Hlatky R, Suki D, Yang D, Weinberg J, Gilbert M, Sawaya R, Aldape K.

Clin Cancer Res. 2005 Feb 15;11(4):1462-6.

12.
13.

Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation.

Li S, Kim JS, Kim JM, Cho MJ, Yoon WH, Song KS, Yeo SG, Kim JS.

Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):705-12. Epub 2006 May 11.

PMID:
16690221
14.

Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.

Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT.

Cancer. 2007 Feb 15;109(4):658-67. Erratum in: Cancer. 2009 May 1;115(9):2024. Reseetkova, Erika [corrected to Resetkova, Erika].

15.
16.
17.

Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.

Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME.

Cancer Res. 2000 Jun 1;60(11):3081-7.

18.

Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status.

Torregrosa D, Bolufer P, Lluch A, López JA, Barragán E, Ruiz A, Guillem V, Munárriz B, García Conde J.

Clin Chim Acta. 1997 Jun 27;262(1-2):99-119.

PMID:
9204213
19.

Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.

Derin D, Eralp Y, Ozluk Y, Yavuz E, Guney N, Saip P, Igci A, Ozmen V, Kücücük S, Aslay I, Aydiner A, Topuz E.

Cancer Invest. 2008 Aug;26(7):671-9. doi: 10.1080/07357900801891628.

PMID:
18608215

Supplemental Content

Support Center